Advertisement

Endothelin-1-Induced Ischemic Damage and Functional Impairment Is Mediated Primarily by NR2B-Containing NMDA Receptors

  • Andrew W. Hume
  • R. Andrew TaskerEmail author
Original Article
  • 4 Downloads

Abstract

Ischemic stroke accounts for 70–80% of stroke cases worldwide and survivors are frequently left with compromising sensorimotor deficits localized to one or more body regions. Most animal models of stroke involve transient or permanent occlusion of one or more major vessels such as the middle cerebral artery and are characterized by widespread damage to cortical and subcortical structures that result in deficits that can confound studies of neuroprotection and neurorehabilitation. Localized microinjections of the vasoconstricting peptide endothelin-1 (ET-1) into specific brain regions are becoming increasingly popular for such studies, but the pharmacology of endothelin-induced ischemic damage is poorly understood. To test the hypothesis that NMDA receptors, and particularly those containing the NR2B subunit, are involved in ET-1-mediated excitotoxicity and functional impairment, male CD1 rats (N = 32) were pre-treated with either the non-competitive NMDA antagonist MK-801 or the NR2B-selective antagonist Ro25-6981 (or vehicle) prior to unilateral microinjections of endothelin-1 into the somatosensory cortex and striatum. Rats were then tested using 4 established tests of sensory and/or motor function over 14 days. Lesion volumes were quantified post-mortem using standard histology and image analysis. Results confirmed reproducible lesions and significant deficits in all tests in vehicle-treated rats that were significantly reduced in both drug groups but were not different between drugs, providing evidence that endothelin-induced ischemic damage is mediated almost exclusively by NR2B-containing NMDA receptors.

Keywords

Ischemia Endothelin NMDA receptor Excitotoxicity Somatosensory function 

Notes

Acknowledgments

The authors thank Ms. Debra MacDonald for the technical assistance.

Funding Information

Research funding was provided by Atlantic Innovation Fund grant 193629.

Supplementary material

12640_2019_138_MOESM1_ESM.docx (250 kb)
ESM 1 (DOCX 250 kb).

References

  1. Aarts MM, Tymianski M (2004) Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr Mol Med 4:137–147CrossRefGoogle Scholar
  2. Adkins DL, Voorhees AC, Jones TA (2004) Behavioral and neuroplastic effects of focal endothelin-1 induced sensorimotor cortex lesions. Neuroscience 128:473–486CrossRefGoogle Scholar
  3. Alia C, Spalletti C, Lai S, Panarese A, Lamola G, Bertolucci F, Vallone F, DiGarbo A, Chisari C, Micera S, Caleo M (2017) Neuroplastic changes following brain ischemia and their contribution to stroke recovery: novel approaches in neurorehabilitation. Front Cell Neurosci.  https://doi.org/10.3389/fncel.2017.00076
  4. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davies RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472–476CrossRefGoogle Scholar
  5. Biernaskie J, Corbett D, Peeling J, Wells J, Lei H (2001) A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn Reson Med 46:827–830CrossRefGoogle Scholar
  6. Biernaskie J, Chernenko G, Corbett D (2004) Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci 24:1245–1254CrossRefGoogle Scholar
  7. Carmichael ST (2005) Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2:396–409CrossRefGoogle Scholar
  8. Chan MK, Tong RK, Chung KY (2009) Bilateral upper limb training with functional electrical stimulation in patients with chronic stroke. Neurorehabil Neural Repair 23:357–365CrossRefGoogle Scholar
  9. Deziel RA, Tasker RA (2017) Effects of endothelin-induced prefrontal cortical lesions on delay discounting in the rat. Behav Neurosci 131:11–19CrossRefGoogle Scholar
  10. Deziel RA, Ryan CL, Tasker RA (2015) Ischemic lesions localized to the medial prefrontal cortex produce selective deficits in measures of executive function in rats. Behav Brain Res 293:54–61CrossRefGoogle Scholar
  11. Di X, Bullock R, Watson J, Fatouros P, Chenard B, White F, Corwin F (1997) Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain. Stroke 28:2244–2251CrossRefGoogle Scholar
  12. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8:355–369CrossRefGoogle Scholar
  13. Feys H, Hetebrig J, Wilms G, Dom R, DeWeerdt W (2000) Predicting arm recovery after stroke: value of site of lesion. Acta Neurol Scand 102:371–377CrossRefGoogle Scholar
  14. Gilmour G, Iversen SD, O’Neill MF, Bannerman DM (2004) The effects of intracortical endothelin-1 injections of skilled forelimb use: implications for modeling recovery of function after stroke. Behav Brain Res 150:171–183CrossRefGoogle Scholar
  15. Ginsberg MD (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacol. 55:363–389CrossRefGoogle Scholar
  16. Hsu JE, Jones TA (2006) Contralesional neural plasticity and functional changes in the less-affected forelimb after large and small cortical infarcts in rats. Exp Neurol 201:479–494CrossRefGoogle Scholar
  17. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D’Agostion RB, Wolf PA (2003) The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis 12:119–126CrossRefGoogle Scholar
  18. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 27:2846–2857CrossRefGoogle Scholar
  19. Livingston-Thomas JM, Tasker RA (2013) Animal models of post-ischemic forced use rehabilitation: methods, considerations, and limitations. Exp Transl Stroke Med 5:2 http://www.etsmjournal.com/content/5/1/2 CrossRefGoogle Scholar
  20. Livingston-Thomas JM, Hume AW, Doucette TA, Tasker RA (2013) A novel approach to induction and rehabilitation of deficits in forelimb function in a rat model of focal ischemic stroke. Acta Pharmacol Sin 34:104–112CrossRefGoogle Scholar
  21. Livingston-Thomas JM, McGuire EP, Doucette TA, Tasker RA (2014) Voluntary forced use of the impaired limb following stroke facilitates functional recovery in the rat. Behav Brain Res 261:210–219CrossRefGoogle Scholar
  22. Lozano JD, Abulafia BS, Danton GH, Watson BD, Dietrich WD (2007) Characterization of a thromboembolic photochemical model of repeated stroke in mice. J Neurosci Methods 162:244–254CrossRefGoogle Scholar
  23. Luke LM, Allred RP, Jones TA (2004) Unilateral ischemic sensorimotor cortical damage induces contralesional synaptogenesis and enhances skilled reaching with the ipsilateral forelimb in adult male rats. Synapse 54:187–199CrossRefGoogle Scholar
  24. Moyanova S, Kortenska L, Mitreva RG, Pashova VD, Ngomba RT, Nicoletti F (2007) Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia. Brain Res 1153:58–67CrossRefGoogle Scholar
  25. Nakayama H, Jorgensen HS, Raaschou HO, Olsen TS (1994) Recovery of upper extremity function in stroke patients: the Copenhagen Stroke Study. Arch Phys Med Rehabil 75:394–398CrossRefGoogle Scholar
  26. Nijland R, Kwakkel G, Bakers J, Van Wegen E (2011) Constraint-induced movement therapy for the upper paretic limb in acute or sub-acute stroke: a systematic review. Int J Stroke 6:425–433CrossRefGoogle Scholar
  27. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, sixth edn. Elsevier/Academic Press, New YorkGoogle Scholar
  28. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacol. 39:777–787CrossRefGoogle Scholar
  29. Sharkey J, Butcher SP, Kelly JS (1994) Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801. J Auton Nerv Syst 49:s177–s185CrossRefGoogle Scholar
  30. Sheskin DJ (2004) Handbook of parametric and non-parametric statistical procedures, third edn. CRC Press, West Palm Beach FLCrossRefGoogle Scholar
  31. Sughrue ME, Mocco J, Komotor RJ, Mehra A, D’Ambrosio AL, Grobelny BT, Penn DL, Connolly ES Jr (2006) An improved test of neurological dysfunction following transient focal cerebral ischemia in rats. J Neurosci Methods 151:83–89CrossRefGoogle Scholar
  32. Sun HS, Doucette TA, Liu Y, Fang Y, Teves L, Aarts M, Ryan CL, Bernard PB, Lau A, Forder JP, Salter MW, Wang YT, Tasker RA, Tymianski M (2008) Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke 39:2544–2553CrossRefGoogle Scholar
  33. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson CM, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290–293CrossRefGoogle Scholar
  34. Vahid-Ansari F, Lagace DC, Albert PR (2016) Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke. Transl Psychiatry 6:e863CrossRefGoogle Scholar
  35. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD (1985) Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 17:497–504CrossRefGoogle Scholar
  36. Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J, Corbett D (2006) An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 201:324–334CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Biomedical SciencesUniversity of Prince Edward IslandCharlottetownCanada
  2. 2.Translational Neuropsychiatry Unit, Clinical MedicineAarhus UniversityAarhusDenmark

Personalised recommendations